The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of the combination of daratumumab, ixazomib, pomalidomide, and dexamethasone as salvage therapy in relapsed/refractory multiple myeloma: Stage 2 interim results.
 
Anupama Deepa Kumar
No Relationships to Disclose
 
Michelle Padilla
No Relationships to Disclose
 
Lin Liu
No Relationships to Disclose
 
Minya Pu
No Relationships to Disclose
 
Emily Pittman
No Relationships to Disclose
 
Dimitrios Tzachanis
Consulting or Advisory Role - Bristol-Myers Squibb; Partner Therapeutics; Takeda
Research Funding - BMS Brazil
 
Sarah Marie Larson
Stock and Other Ownership Interests - 1200 Pharma; Torl Biotherapeutics
Research Funding - Abbvie; Allogene Therapeutics (Inst); BiolineRx; Bristol-Myers Squibb; Celgene; Janssen Oncology; Novartis; Pfizer (Inst); Sanofi (Inst)
 
Nina Shah
Consulting or Advisory Role - Amgen; CareDX; CSL Behring; Genentech/Abbvie; GlaxoSmithKline; Indapta Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; Oncopeptides; Sanofi
Research Funding - Bluebird Bio; Celgene; Cellectis; Janssen; Nektar; poseida therapeutics; Precision Biosciences; Sutro biopharma; Teneobio
 
Carolyn M. Mulroney
Stock and Other Ownership Interests - Bristol-Myers Squibb; Pfizer
Consulting or Advisory Role - Pharmacyclics
Travel, Accommodations, Expenses - Pharmacyclics
 
Edward David Ball
Stock and Other Ownership Interests - Abbvie (I); Anthem Blue Cross Blue Shield (I); Bristol-Myers Squibb/Medarex (I); Merck (I)
 
Aaron Seth Rosenberg
Consulting or Advisory Role - Amgen; Karyopharm Therapeutics; Seagen
Speakers' Bureau - Janssen; Takeda
Research Funding - Amgen; Amgen (Inst)
 
Caitlin Costello
Honoraria - Celgene; Janssen; Karyopharm Therapeutics; Oncopeptides; Takeda
Consulting or Advisory Role - Celgene; Takeda
Research Funding - Celgene (Inst); Janssen (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Takeda